A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination with Immune Therapies in Subjects with Advanced or Metastatic Malignancies December 14, 2017 Type of Cancer Unknown Sponsor Incyte Protocol Number INCAGN 1949-201 To Learn More Call 201-510-0910